Societe Generale’s Integra LifeSciences IART Stock Holding History

Societe Generale’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$106K	Buy	+2,650	New	+$95.3K	﹤0.01%	2367

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Societe Generale's IART Position: Q2 2016 in Review

Societe Generale opened a new position in Integra LifeSciences (IART) in Q2 2016: 2,650 shares worth $106K. The stake represents ﹤0.01% of the portfolio and ranks #2367 among its holdings.

210 funds tracked by Wall St. Rank hold IART as of Q2 2016.

Societe Generale held 2,650 shares of Integra LifeSciences worth $106K as of Q2 2016.
Integra LifeSciences was a new Societe Generale position in Q2 2016.
Integra LifeSciences made up ﹤0.01% of Societe Generale's portfolio in Q2 2016, its #2367 holding.
210 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.